3D printed personalized therapies for pediatric patients affected by adrenal insufficiency.

Lucía Rodríguez-PomboConcepción Gallego-FernándezAnna Kirstine JørgensenCarlos Javier Parramón-TeixidóCarme Cañete-RamirezMaria Josep Cabañas-PoyAbdul W BasitCarmen Alvarez-LorenzoAlvaro Goyanes

Published in: Expert opinion on drug delivery (2024)

The results confirm the suitability and safety of the developed printlets for use in the clinical trial. The required technical information from The Spanish Medicines Agency for this clinical trial application was compiled to serve as guideline for healthcare professionals seeking to apply for and conduct clinical trials on 3DP oral dosage forms.

Keyphrases

clinical trial
phase ii
open label
double blind
study protocol
mental health
placebo controlled